Lupin Limited has informed the Exchange regarding a press release dated July 31, 2026, titled "Lupin Announces the Approval of Diazepam Injection, USP in the United States".
Lupin Limited Press Release Jul 31 2026
Earlier from Lupin
- Lupin Announces U.S. FDA Approval and Launch of Sugammadex Injection
- Lupin Limited Press Release Jul 14 2026